Michael R. Gralinski
CEO & Co-Founder at CorDynamics- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
CorDynamics
-
United States
-
Biotechnology
-
1 - 100 Employee
-
CEO & Co-Founder
-
2002 - Present
I leverage my professional experience to help our biopharmaceutical clients address their cardiovascular discovery and safety questions throughout the drug development process. I lead a highly skilled team that conducts exploratory through regulatory compliant studies in our laboratories. www.cordynamics.com www.slideshare.net/CorDynamics I leverage my professional experience to help our biopharmaceutical clients address their cardiovascular discovery and safety questions throughout the drug development process. I lead a highly skilled team that conducts exploratory through regulatory compliant studies in our laboratories. www.cordynamics.com www.slideshare.net/CorDynamics
-
-
-
-
Principal Consultant
-
2019 - Present
I provide guidance to biotechnology, pharmaceutical, and equity/venture capital clients with cardiovascular challenges in the drug discovery, safety, and development space. My involvement with hundreds of projects over 30+ years helps provide integrated cardiovascular risk assessments for client IP, which facilitates confident go/no-go decision making and backup strategies. I provide guidance to biotechnology, pharmaceutical, and equity/venture capital clients with cardiovascular challenges in the drug discovery, safety, and development space. My involvement with hundreds of projects over 30+ years helps provide integrated cardiovascular risk assessments for client IP, which facilitates confident go/no-go decision making and backup strategies.
-
-
-
Cor3D Biosciences
-
Chicago, IL
-
Founder
-
2019 - Present
Cor3D reviews visionary and nascent technologies involving human [stem]cellular and multi-dimensional cardiac organoid preparations for potential application in the cardiovascular discovery and drug safety space. Cor3D reviews visionary and nascent technologies involving human [stem]cellular and multi-dimensional cardiac organoid preparations for potential application in the cardiovascular discovery and drug safety space.
-
-
-
-
Master of Ceremonies
-
2018 - 2019
Rare Storytellers is a rapidly growing network of patients and caregivers associated with rare disease. The team educates medical students and nascent health care professionals on the challenges faced by these individuals. Rare Storytellers raises funds to support these endeavors as well as for scientific research in this space through its registered non-profit status. Rare Storytellers is a rapidly growing network of patients and caregivers associated with rare disease. The team educates medical students and nascent health care professionals on the challenges faced by these individuals. Rare Storytellers raises funds to support these endeavors as well as for scientific research in this space through its registered non-profit status.
-
-
-
Harmony 4 Hope
-
United States
-
Philanthropic Fundraising Services
-
1 - 100 Employee
-
Vice President and Board Director
-
2014 - 2019
Harmony 4 Hope is a Chicago based charitable organization. I was a Co-Founder of the company in 2014 and our goal was to implement music centered initiatives that contribute to the betterment of those battling rare disease. The non-profit also supports scientific discoveries in the Rare Disease Space. Harmony 4 Hope is a Chicago based charitable organization. I was a Co-Founder of the company in 2014 and our goal was to implement music centered initiatives that contribute to the betterment of those battling rare disease. The non-profit also supports scientific discoveries in the Rare Disease Space.
-
-
-
Safety Pharmacology Society
-
United States
-
Research Services
-
1 - 100 Employee
-
President
-
Jan 2004 - Dec 2004
Elected to multiple positions on the Executive Council and Board of Directors, including Treasurer, Vice President, and President. Safety Pharmacology Society is a nonprofit corporation that supports the human safety of drugs and biologicals by fostering scientific research, education, and dissemination of scientific information through meetings and other scientific interactions. Elected to multiple positions on the Executive Council and Board of Directors, including Treasurer, Vice President, and President. Safety Pharmacology Society is a nonprofit corporation that supports the human safety of drugs and biologicals by fostering scientific research, education, and dissemination of scientific information through meetings and other scientific interactions.
-
-
-
-
R&D
-
2000 - 2002
Directed product safety and toxicology operations, lead resolution efforts for issues involving drug discovery and development, as well as cultivated relationships with international colleagues throughout small and large pharma. Directed product safety and toxicology operations, lead resolution efforts for issues involving drug discovery and development, as well as cultivated relationships with international colleagues throughout small and large pharma.
-
-
-
-
R&D
-
1997 - 2000
Director - Safety Pharmacology Director - Safety Pharmacology
-
-
-
Parke-Davis
-
United States
-
1 - 100 Employee
-
R&D
-
1996 - 1997
-
-
-
University of Michigan
-
United States
-
Higher Education
-
700 & Above Employee
-
R&D
-
1992 - 1996
-
-
Education
-
University of Michigan
Ph.D., Pharmacology (Cardiovascular) -
University of Wisconsin-Madison
B.S., Pharmacology & Toxicology